← Back to Search

Customized Handoff Protocols for ICU Patient Safety (HATRICC-US Trial)

N/A

Waitlist Available

Led By Meghan B Lane-Fall, MD, MSHP

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at quarterly intervals starting year 1, quarter 2 and continuing until the end of year 5.

Awards & highlights

No Placebo-Only Group

Summary

This trial will adapt, implement, and evaluate protocols for postoperative handoffs in order to improve patient outcomes in acute care settings.

Who is the study for?

This trial is for English-speaking adults who are admitted to the study hospitals for inpatient care and will experience a handoff from surgery to intensive care. It's also for healthcare workers involved in surgical patient care or with administrative duties related to patient care at these hospitals.

What is being tested?

The study is testing customized post-operative handoff protocols between healthcare teams, aiming to improve communication and patient safety in critical care settings by using implementation science and engineering principles.

What are the potential side effects?

Since this trial focuses on improving communication procedures rather than medical treatments, there are no direct physical side effects. However, changes in protocol may affect workflow efficiency and stress levels among staff.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at quarterly intervals starting year 1, quarter 2 and continuing until the end of year 5.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at quarterly intervals starting year 1, quarter 2 and continuing until the end of year 5.

This trial's timeline: 3 weeks for screening, Varies for treatment, and at quarterly intervals starting year 1, quarter 2 and continuing until the end of year 5. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adherence to standardized handoff intervention (Fidelity) measured by number of handoff steps followed.

New-onset organ failure

Secondary study objectives

AHRQ PSI 10: Postoperative physiologic or metabolic derangement rate (effectiveness)

Respiratory Failure

AHRQ PSI 12: Perioperative pulmonary embolism or DVT rate (effectiveness)

+13 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Customized Or to ICU handoff protocolExperimental Treatment1 Intervention

Tailored implementation strategies will be used in 12 ICUs to facilitate the uptake and sustained use of a customized handoff protocol to be used by clinicians at the time of patient care transition from the operating room to the intensive care unit.

0 / 1Eligibility criteria met